Mumbai: The three potential Covid-19 vaccines that have released Phase-3 trial results have shown very high efficacy rates compared to most vaccines that are under use and specifically in comparison with the flu vaccines.

While Moderna and Pfizer NSE -0.43 % have reported over 95% efficacy, the AstraZeneca-Oxford vaccine has a rate of up to 90% and an average of 70.4% if results of two different dosing regimes are combined.

Source: Livemint


By Editor

We Try To Share All important Information With You.

Leave a Reply

Your email address will not be published. Required fields are marked *